ES2057053T3 - Compuestos benzoheterociclicos. - Google Patents

Compuestos benzoheterociclicos.

Info

Publication number
ES2057053T3
ES2057053T3 ES89119239T ES89119239T ES2057053T3 ES 2057053 T3 ES2057053 T3 ES 2057053T3 ES 89119239 T ES89119239 T ES 89119239T ES 89119239 T ES89119239 T ES 89119239T ES 2057053 T3 ES2057053 T3 ES 2057053T3
Authority
ES
Spain
Prior art keywords
compounds
benzoheterociclicos
reduced
atomo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89119239T
Other languages
English (en)
Inventor
Hisashi Miyamoto
Hiroshi Yamashita
Michiaki Tominaga
Yoichi Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2057053T3 publication Critical patent/ES2057053T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

NUEVOS COMPUESTOS 3 - FORMIL - 4 - OXOQUINOLINA DE FORMULA (I) DONDE R'' ES UN ATOMO DE HIDROGENO O UN ALCANOILICO REBAJADO, R2 ES UN ATOMO DE HIDROGENO O UN ALQUILICO REBAJADO, R3 ES UN ALQUILICO REBAJADO Y X ES UN HALOGENO Y SALES ACEPTADAS FARMACEUTICAMENTE DEL MISMO, DICHOS COMPONENTES TIENEN UNA EXCELENTE ACTIVIDAD ANTIMICROBIAL Y UNA COMPOSICION FARMACEUTICA QUE CONTIENE DICHO COMPONENTE COMO INGREDIENTE ACTIVO.
ES89119239T 1988-10-20 1989-10-17 Compuestos benzoheterociclicos. Expired - Lifetime ES2057053T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26583088 1988-10-20
JP1236642A JP2777661B2 (ja) 1988-10-20 1989-09-12 ベンゾヘテロ環化合物

Publications (1)

Publication Number Publication Date
ES2057053T3 true ES2057053T3 (es) 1994-10-16

Family

ID=26532772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89119239T Expired - Lifetime ES2057053T3 (es) 1988-10-20 1989-10-17 Compuestos benzoheterociclicos.

Country Status (8)

Country Link
US (1) US4971970A (es)
EP (1) EP0364943B1 (es)
JP (1) JP2777661B2 (es)
KR (1) KR0141606B1 (es)
CN (1) CN1028230C (es)
DE (1) DE68915928T2 (es)
DK (1) DK519389A (es)
ES (1) ES2057053T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
JP3484025B2 (ja) * 1996-01-10 2004-01-06 仲道 山崎 連続水熱合成方法および装置
DE60101724T2 (de) * 2001-03-30 2004-12-02 Dar Al Dawa Development, And Investment Co. Chinolin-4-on Derivate und deren Verwendung als Antibiotika
AU2010247141A1 (en) 2009-05-15 2011-12-15 Redx Pharma Plc Redox drug derivatives
CN113057168B (zh) * 2021-03-22 2022-02-11 云南中烟工业有限责任公司 一种种子消毒制剂、其制备方法、使用方法和用途
CN113087664B (zh) * 2021-03-22 2022-03-11 云南中烟工业有限责任公司 一种喹啉生物碱类化合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4620007A (en) * 1980-09-03 1986-10-28 Bayer Aktiengesellschaft 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.

Also Published As

Publication number Publication date
CN1028230C (zh) 1995-04-19
CN1042540A (zh) 1990-05-30
EP0364943A3 (en) 1991-06-12
DK519389A (da) 1990-04-21
JPH02191257A (ja) 1990-07-27
US4971970A (en) 1990-11-20
KR0141606B1 (ko) 1998-06-01
DE68915928T2 (de) 1994-09-22
EP0364943A2 (en) 1990-04-25
EP0364943B1 (en) 1994-06-08
DK519389D0 (da) 1989-10-19
KR900006316A (ko) 1990-05-07
JP2777661B2 (ja) 1998-07-23
DE68915928D1 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
PT650476E (pt) Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2171416T3 (es) Remedio contra la trombocitopenia.
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BR0015605A (pt) Composição e uso
TW234691B (es)
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
DE69322251D1 (de) Medizinische zusammensetzung
ES2113358T3 (es) Composiciones antidiarreicas.
SE8804628D0 (sv) New compounds
ES2057053T3 (es) Compuestos benzoheterociclicos.
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
DE69519385T2 (de) Chinazolinon-arzneimittel sowie deren verwendung
PT1187611E (pt) Composicoes oftalmicas de histamina e sua utilizacoes
YU47338B (sh) Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
DK0672043T3 (da) Hidtil ukendte 4-(3-benzofuranyl)-piperidinyl- og 4-(3-benzothienyl)-piperidinyl-derivater og farmaceutiske præparater indeholdende dem
ES2054186T3 (es) Composicion antihepatopatica.
DK1059845T3 (da) Fungicid sammensætning omfattende et benzoylphenylurinstof
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 364943

Country of ref document: ES